MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    A Benign Course of Parkinson’s Disease Associated with Different Mutations in the Glucocerebrosidase (GBA) Gene – a Case Series.

    M. Cohen, Y. Schechter, R. Eichel, G. Yahalom (Jerusalem, Israel)

    Objective: To describe a subtype of GBA-associated Parkinson's disease with a benign motor and cognitive course of disease. Background: Subjects carrying mutations in the GBA…
  • 2024 International Congress

    Young-onset Parkinson’s disease in a female with pathogenic deletion of the PRRT2 gene

    M. Chen, M. Christie (Houston, USA)

    Objective: To report a novel case of young-onset Parksinon’s disease (YOPD) associated with a pathogenic deletion of the proline-rich transmembrane protein 2 gene (PRRT2). Background:…
  • 2024 International Congress

    Engagement of the Black and African American Community in Parkinson’s Genetic Research

    E. Stevens, A. Kumeh, S. Sauveur, D. Oguoma-Richards, R. Huckabee, A. Huckabee, D. Coley, B. Coley, M. Fitts, E. Lewis, L. Seghetti, T. Best, K. Gamble, K. Williams, L. Wilson, R. Joseph, H. Shah, C. Gallagher, C. Evers, J. Beck, A. Naito, C. Branson (New York, USA)

    Objective: Increase racial diversity in Parkinson’s disease (PD) genetic research by engaging Black and African American people living with PD Background: Advancements in understanding the…
  • 2024 International Congress

    Expanding the PD GENEration Study to increase clinical genetic testing and counseling using whole genome sequencing among diverse Parkinson’s disease (PD) populations

    K. Ghosh Galvelis, A. Naito, M. Dini, S. Rao, R. Deleon, A. Coral-Zambrano, T. Foroud, P. Hodges, L. Heathers, J. Verbrugge, L. Cook, J. Schulze, M. Totten, A. Hall, K. Marder, I. Mata, N. Mencacci, T. Simuni, M. Nance, M. Schwarzschild, A. Wills, S. Lawrence, P. Ponger, J. Beck, R. Alcalay (New York, USA)

    Objective: To provide Clinical Laboratory Improvement Amendments (CLIA) genetic testing using whole genome sequencing and disclosure of 7 PD relevant genes and secondary health-related genetic…
  • 2024 International Congress

    A new phenotype-genotype correlation for FIG4 gene and Parkinson’s disease

    I. Boura, G. Xiromerisiou, I A. Giannopoulou, P. Mitsias, C. Spanaki (HERAKLION, Greece)

    Objective: We present a patient with atypical Parkinson’s disease (PD), carrying a homozygous missense mutation of FIG4. Background: FIG4 is involved in endosomal-lysosomal trafficking and…
  • 2024 International Congress

    Exploring the neural correlates of impulsivity and impulsive compulsive behaviors in Parkinson’s disease

    E. Ubeda Matzilevich, B. Swinnen, L. Ricciardi, S. Little (San Francisco, USA)

    Objective: To explore the subcortical neural correlates of impulse control and related behavioral disorders (ICBD) and trait impulsivity in a chronic and naturalistic setting in…
  • 2024 International Congress

    Analysing the bradykinesia features combination in people with Parkinson’s disease and elderly healthy individuals

    G. Paparella, M. de Riggi, A. Cannavacciuolo, D. Costa, D. Birreci, M. Passaretti, L. Angelini, A. Berardelli, M. Bologna (rome, Italy)

    Objective: To evaluate, through kinematic analysis, the major phenomenological features of bradykinesia, with a specific focus on their combination, in a relatively large sample of…
  • 2024 International Congress

    Muscle Augmentation Paradox: Contrasting Therapeutic Approaches in Myasthenia Gravis and Parkinson’s Disease

    G. Legerme, D. Nolasco, A. Sohel, A. Wu, B. Carr (Gainesville, USA)

    Objective: This exploration aims to dissect the therapeutic paradox presented by muscle augmentation strategies in Myasthenia Gravis (MG) and Parkinson's Disease (PD), offering a comparative…
  • 2024 International Congress

    Alterations in Monoamine Metabolites in Parkinson’s Disease: A Meta-Analysis

    MA. Muneer, V. Suresh, E. Zulfiqar, S. Saaki, I. Jaffery, V. Chowdary, S. Hurjkaliani (Lahore, Pakistan)

    Objective: To analyze the levels of various monoamine metabolites in patients with Parkinson’s Disease as compared to healthy controls. Background: Monoamine metabolites are the breakdown…
  • 2024 International Congress

    Education Levels on Diagnostic Delay Phase and Initial Symptom Perception Among Hispanic Patients with Parkinson’s Disease: A Cross-Sectional Study

    C. Rodriguez-Alarcon, D. Piana-Castillo, G. Faggioni-Sanchez, D. Bustamante-Mieles, M. Barreiro-Guillén, C. Cevallos-Velasco, R. Santibanez-Vasquez (Guayaquil, Ecuador)

    Objective: Determine the relationship between education levels and the diagnostic delay phase, along with the age of symptom perception, in Hispanic patients with Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 131
  • 132
  • 133
  • 134
  • 135
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley